Growth of $10,000


Fund Documents


Investment Strategy:

KDIV gives investors access to the S&P Dividend Aristocrats methodology applied to the Pan Asia region, one of the fastest-growing areas in the world. The S&P Pan Asia Dividend Aristocrats Index includes companies from China, Japan, Australia, and other Asian countries, that have paid and increased their dividends over a sustained period of time. Over the long term, companies with a strong track record of paying and growing dividends may outperform the broad market on a risk-adjusted basis.

Why Dividend Growth?

  • As a decade of low-interest rates ends, investors are increasingly searching for growth and income in their portfolios. Simultaneously, as global equity market volatility increases, investors may want defensive strategies to weather market turbulence.
  • Adding dividend growers to an investment portfolio may result in lower volatility, compounded growth on dividend reinvestment, and reduced drawdown in declining markets.
  • Strong dividend growth is generally a positive signal from company insiders of confidence in the future of the business, as well as a pro-shareholder orientation.

Why Pan Asia Region?

  • The International Monetary Fund forecasts GDP growth in the Asia Pacific region to be 4.9% in 2022 and 5.1% in 2023.1
  • While much of the western world is actively tightening monetary policy, major Asian central banks have remained more accommodative.
  • From 2009 to 2021, Asia Dividend Aristocrats averaged a higher yield than the S&P Pan Asia Broad Market Index (BMI).1

1. “The Case for Dividend Aristocrats in Pan Asia”, S&P Dow Jones Indices, Aug 29, 2022. Gross domestic product (GDP) is a monetary measure of the market value of all the final goods and services produced in a specific time period by a country.

Premium Discount Chart

Daily Performance

Data as of 05/25/2023
Daily Net Asset Value (NAV) and Market Price
NAV $26.47
NAV Daily Change -0.26%
Market Price $26.61
Market Price Daily Change 0.57%
30 Day Median Bid/Ask Spread

Performance History

Cumulative %
Data as of: 04/30/2023
Fund NAV Closing Price Index
1 Month 2.21% 2.35% 2.12%
3 Month -1.21% -1.03% -1.08%
6 Month 26.36% 26.73% 26.90%
Since Inception 8.42% 8.83% 8.62%
Cumulative %
Data as of quarter end: 03/31/2023
Fund NAV Closing Price Index
Since Inception 6.08% 6.33% 6.36%

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Growth of $10,000

Data as of 05/25/2023

The Growth of $10,000 chart reflects an initial investment of $10,000 on the day prior to the selected time period and assumes reinvestment of dividends and capital gains. For the growth of $10,000 chart since inception, the initial investment of $10,000 is instead made on the inception date of the Fund. Fund expenses, including management fees and other expenses were deducted. The growth of a $10,000 investment in the fund is hypothetical and for illustration purposes only.

Top 10 Holdings

Data as of 05/26/2023 Full Holdings .CSV
Rank Name % of Net Assets Ticker Identifier Shares Held Market Value($)
1 WISTRON CORP 8.15% 3231 TW0003231007 102,000 215,669
2 JB HI-FI LTD 3.32% JBH AU000000JBH7 3,063 87,763
3 CKI HOLDINGS 3.10% 1038 BMG2178K1009 15,000 82,037
4 SINOPHARM GROUP CO-H 3.06% 1099 CNE100000FN7 24,000 81,023
5 GUANGDONG INVESTMENT LTD 2.97% 270 HK0270001396 90,000 78,687
6 LONGFOR GROUP HO 2.39% 960 KYG5635P1090 31,500 63,202
7 PING AN-H 2.34% 2318 CNE1000003X6 9,500 62,021
8 APA GROUP 2.31% APA AU000000APA1 9,326 61,114
9 HONG KONG & CHINA GAS 2.30% 3 HK0003000038 65,000 60,812
10 CHINA MEDICAL SY 2.25% 867 KYG211081248 39,000 59,434

Holdings are subject to change.